Despite therapeutic advances that have changed the landscape of rheumatoid arthritis treatment over the past decade, work disability rates among RA patients remain "unacceptably high,"...
Dr. Howard Scher discusses MDV3100, a novel oral androgen receptor antagonist. The agent is under study for the treament of castrate-resistant prostate cancer. Patrice Wendling...
Some 80% of patients who undergo percutaneous coronary intervention for acute coronary syndrome with left main coronary disease survive for 6 months beyond their initial...
An investigational device can discriminate normal cells from cancerous cells in sputum with 90% sensitivity and near 100% specificity, according to its manufacturer, VisionGate, Inc....
Dr. Nassir Ghaemi says amphetamines should be used only as a last resort and mainly for short-term treatment in ADHD and bipolar disorder. Patrice Wendling...
Dr. Vincent A. Miller describes study results that suggest the addition of erlotinib to bevacizumab treatment for advanced non-small cell lung cancer extends progression-free survival...
Dr. Eric Van Cutsem discusses how trastuzumab may be able to provide a significant survival advantage for gastric cancer patients whose tumors carry the HER2...
The already rapidly evolving array of cosmetic dermatology products is about to expand again, speakers said at a cosmetic dermatology seminar sponsored by the Skin...
